Jean‐Philippe Coppé

机构：University of California, San Francisco · ORCID：0000-0002-0890-8326

发表论文 79 篇 · 总被引 19441 次 · h-index 24

代表论文

• Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies (2023 · Journal of Clinical Investigation · 被引 45)
• A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors (2023 · Nature Cancer · 被引 45)
• Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial (2023 · Cell Reports Medicine · 被引 18)
• The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma (2024 · Molecular Cancer · 被引 15)
• B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer (2023 · Breast Cancer Research · 被引 14)
• Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype (2025 · Cellular and Molecular Life Sciences · 被引 1)